GuidelineAnnals of hematology2025
Updated Egyptian national guidelines for management of hemophilia A in children & adolescents.
Guideline in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To improve patient advocacy in hemophilia, the World Federation of Hemophilia (WFH) recommends establishing a National Hemophilia Committee (NHC), developing standards and guidelines, broadening the community through including people with von Willebrand disease, other rare bleeding disorders and carriers of hemophilia. In 2018, the Egyptian Society of Hemophilia (ESH) took the initiative, developed, and published guidelines for Hemophilia A care [1] (Table 1). Aim & Methods given the cmanagement, the panel `s goal was to update the ESH guidelines for Hemophilia A care using the modified Delphi method to address unmet needs and local requirements in Egyptian healthcare settings and include management of obesity in hemophilia patients, oral health promotion and prophylaxis before dental procedures, routine monitoring of bleeding events and musculoskeletal scoring, treatment of central nervous system bleeding in children and neonates with hemophilia, the management of acquired hemophilia and hemophilia carrier, the use and monitoring of Non-factor replacement in prophylaxis, finally the implementation of transitional care and patient advocacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.